Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Minority Interest (2018 - 2025)

Historic Minority Interest for Evogene (EVGN) over the last 8 years, with Q3 2025 value amounting to $1.3 million.

  • Evogene's Minority Interest fell 9202.1% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 9202.1%. This contributed to the annual value of $16.3 million for FY2024, which is 206.23% down from last year.
  • Latest data reveals that Evogene reported Minority Interest of $1.3 million as of Q3 2025, which was down 9202.1% from $15.9 million recorded in Q2 2025.
  • Over the past 5 years, Evogene's Minority Interest peaked at $16.9 million during Q2 2024, and registered a low of -$3.2 million during Q4 2022.
  • Moreover, its 5-year median value for Minority Interest was $1.3 million (2025), whereas its average is $5.7 million.
  • As far as peak fluctuations go, Evogene's Minority Interest skyrocketed by 133831.22% in 2024, and later crashed by 233333.33% in 2025.
  • Evogene's Minority Interest (Quarter) stood at -$2.7 million in 2021, then decreased by 20.89% to -$3.2 million in 2022, then surged by 618.78% to $16.6 million in 2023, then plummeted by 109.43% to -$1.6 million in 2024, then surged by 184.32% to $1.3 million in 2025.
  • Its Minority Interest stands at $1.3 million for Q3 2025, versus $15.9 million for Q2 2025 and -$402000.0 for Q1 2025.